Previous publications have suggested the Amalgatome SD (ASD) may reduce operating time. The poster study presented by Dr. Alan Pang of Texas Tech University Health Sciences Center, proved the ASD operating time was significantly shorter in patients with greater than 25% TBSA.
Read more
Exsurco Medical is pleased to announce that a peer-reviewed consensus white paper has been published in the ePlasty Journal on: "Consensus on the Benefits of the Exsurco Medical Amalgatome SD in the Treatment of Burns and Other Wounds." The advisory panel found that the Amalgatome ®SD Skin Grafting and Wound Debridement Device provides better speed, […]
Clinical summary and white paper on Amalgatome® SD vs. conventional dermatome use Recently a retrospective clinical animal study was released with the goal to measure viability of skin grafts, thickness and consistency of excised grafts, time to granulation and re-epithelialization, donor site, and device ease of use. The studies used the Exsurco Medical Amalgatome® SD […]
